rs74847855
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006785.4(MALT1):āc.649A>Gā(p.Arg217Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0369 in 1,587,716 control chromosomes in the GnomAD database, including 1,300 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_006785.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MALT1 | NM_006785.4 | c.649A>G | p.Arg217Gly | missense_variant, splice_region_variant | 4/17 | ENST00000649217.2 | NP_006776.1 | |
LOC105372146 | XR_935537.3 | n.62-3324T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MALT1 | ENST00000649217.2 | c.649A>G | p.Arg217Gly | missense_variant, splice_region_variant | 4/17 | NM_006785.4 | ENSP00000497997 | P3 | ||
ENST00000588835.1 | n.57-3324T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0284 AC: 4322AN: 152216Hom.: 101 Cov.: 32
GnomAD3 exomes AF: 0.0371 AC: 8313AN: 224104Hom.: 189 AF XY: 0.0394 AC XY: 4780AN XY: 121326
GnomAD4 exome AF: 0.0378 AC: 54226AN: 1435382Hom.: 1199 Cov.: 30 AF XY: 0.0390 AC XY: 27825AN XY: 713410
GnomAD4 genome AF: 0.0283 AC: 4314AN: 152334Hom.: 101 Cov.: 32 AF XY: 0.0285 AC XY: 2126AN XY: 74498
ClinVar
Submissions by phenotype
Combined immunodeficiency due to MALT1 deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at